NCT04599478View on ClinicalTrials.gov

Pharmacological and Behavioral Treatment After Bariatric Surgery: Acute (Stage 1)

PHASE2/PHASE3RecruitingINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

June 29, 2021

Primary Completion Date

January 31, 2026

Study Completion Date

January 31, 2027

Conditions
Loss-of-control EatingObesity/Overweight
Interventions
DRUG

Naltrexone and Bupropion medication

NB medication will be taken daily in pill form.

BEHAVIORAL

Behavioral Weight Loss

Behavioral Weight Loss (BWL) counseling includes weekly sessions.

OTHER

Placebo

Placebo will be inactive and taken daily in pill form.

Trial Locations (1)

06510

RECRUITING

Yale Department of Psychiatry, New Haven

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Yale University

OTHER